Schwarz Pharma Manufacturing, Inc. - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Schwarz Pharma Manufacturing, Inc.

Pharmaceutical Technology

Corporate description



At Schwarz Pharma, Inc., we have the facility; the equipment; the professional, experienced staff; and the commitment to be your full-service contract manufacturer. Our services include all phases of manufacturing, from product development to the distribution of your product. You select the services you require.

Schwarz Pharma achieves excellence via investment in people, systems, and procedures, process optimization, and infrastructure. We can assure you a well-trained team, modern facilities, and product quality that meet your specifications.

You can place your product here with confidence.

Technical services

Solid-dose manufacturing

Facilities

Over 250,000 ft2 of manufacturing facilities located in Seymour, Indiana.

Markets served

Multinational market presence.












Schwarz Pharma Manufacturing, Inc.

1101 "C" Ave. West
Seymour, IN 47274

TELEPHONE
812.523.5490

FAX
812.523.1887

NUMBER OF EMPLOYEES
350 US
4000 worldwide

DATE FOUNDED
1946

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
27%
Breakthrough designations
9%
Protecting the supply chain
41%
Expedited reviews of drug submissions
9%
More stakeholder involvement
14%
View Results
Jim Miller Outsourcing Outlook Jim Miller Health Systems Raise the Bar on Reimbursing New Drugs
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerThe Mainstreaming of Continuous Flow API Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler Industry Seeks Clearer Standards for Track and Trace
Siegfried Schmitt Ask the Expert Siegfried SchmittData Integrity
Sandoz Wins Biosimilar Filing Race
NIH Translational Research Partnership Yields Promising Therapy
Clusters set to benefit from improved funding climate but IP rights are even more critical
Supplier Audit Program Marks Progress
FDA, Drug Companies Struggle with Compassionate Use Requests
Source: Pharmaceutical Technology,
Click here